Welch Group’s Boston Scientific BSX Stock Holding History

Welch Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,287	Closed	-$269K	–	327
2026 Q1	$269K	Sell	4,287 -431	-9%	-$34.5K	0.01%	248
2025 Q4	$450K	Buy	4,718 +77	+2%	+$7.55K	0.02%	186
2025 Q3	$453K	Hold	4,641	–	–	0.02%	181
2025 Q2	$498K	Buy	4,641 +159	+4%	+$16.1K	0.02%	158
2025 Q1	$445K	Sell	4,482 -57	-1%	-$5.74K	0.02%	156
2024 Q4	$407K	Buy	4,539 +1,882	+71%	+$166K	0.02%	169
2024 Q3	$223K	Hold	2,657	–	–	0.01%	243
2024 Q2	$205K	Buy	+2,657	New	+$194K	0.01%	247

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Welch Group's BSX Position: Q2 2026 in Review

Welch Group sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,287 shares — an estimated $269K sold.

Welch Group first reported a position in BSX in Q2 2024 and held it in 8 quarters. The position peaked at $498K in Q2 2025. 461 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Welch Group reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Welch Group sold 4,287 Boston Scientific shares in Q2 2026, an estimated $269K.
Welch Group first reported a position in Boston Scientific in Q2 2024 and held it in 8 quarters.
Welch Group's Boston Scientific position peaked at $498K in Q2 2025.
461 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Welch Group's 13F filing for Q2 2026, filed 23 Jul 2026.